Literature DB >> 18049225

Radiation dosimetry for highly contaminated Belarusian, Russian and Ukrainian populations, and for less contaminated populations in Europe.

André Bouville1, Illya A Likhtarev, Lina N Kovgan, Victor F Minenko, Sergei M Shinkarev, Vladimir V Drozdovitch.   

Abstract

The explosions at the Chernobyl Nuclear Power Plant (CNPP) in Ukraine early in the morning of 26 April 1986 led to a considerable release of radioactive materials during 10 d. The cloud from the reactor spread many different radionuclides, particularly those of iodine (131I) and cesium (134Cs and 137Cs), over the majority of European countries, but the greatest contamination occurred over vast areas of Belarus, the Russian Federation and Ukraine. As the major health effect of Chernobyl is an elevated thyroid cancer incidence in children and adolescents, much attention has been paid to the thyroid doses resulting from intakes of 131I, which were delivered within 2 mo following the accident. The thyroid doses received by the inhabitants of the contaminated areas of Belarus, Russia, and Ukraine varied in a wide range, mainly according to age, level of ground contamination, milk consumption rate, and origin of the milk that was consumed. Reported individual thyroid doses varied up to approximately 40,000 mGy, with average doses of a few to 1,000 mGy, depending on the area where people were exposed. In addition, the presence in the environment of long-lived 134Cs and 137Cs has led to a relatively homogeneous exposure of all organs and tissues of the body via external and internal irradiation, albeit at low rates. Excluding the thyroid doses, the whole-body (or effective) dose estimates for the general population accumulated during 20 y after the accident (1986-2005) range from a few millisieverts (mSv) to some hundred mSv with an average dose of approximately 10 mSv in the contaminated areas of Belarus, Russia, and Ukraine. In other European countries, both the thyroid and the effective doses are, on average, much smaller.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18049225     DOI: 10.1097/01.HP.0000279019.23900.62

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  19 in total

1.  Non-thyroid cancer in Northern Ukraine in the post-Chernobyl period: Short report.

Authors:  M Hatch; E Ostroumova; A Brenner; Z Federenko; Y Gorokh; O Zvinchuk; V Shpak; V Tereschenko; M Tronko; K Mabuchi
Journal:  Cancer Epidemiol       Date:  2015-03-18       Impact factor: 2.984

2.  Quantifying annual internal effective 137Cesium dose utilizing direct body-burden measurement and ecological dose modeling.

Authors:  Benjamin A Jelin; Wenjie Sun; Alexandra Kravets; Maryna Naboka; Eugenia I Stepanova; Vitaliy Y Vdovenko; Wilfried J Karmaus; Alex Lichosherstov; Erik R Svendsen
Journal:  J Expo Sci Environ Epidemiol       Date:  2015-03-11       Impact factor: 5.563

3.  American Thyroid Association Scientific Statement on the Use of Potassium Iodide Ingestion in a Nuclear Emergency.

Authors:  Angela M Leung; Andrew J Bauer; Salvatore Benvenga; Alina V Brenner; James V Hennessey; James R Hurley; Stacey A Milan; Arthur B Schneider; Krishnamurthi Sundaram; Daniel J Toft
Journal:  Thyroid       Date:  2017-06-21       Impact factor: 6.568

4.  Neonatal outcomes following exposure in utero to fallout from Chernobyl.

Authors:  Maureen Hatch; Mark P Little; Alina V Brenner; Elizabeth K Cahoon; Valery Tereshchenko; Ludmyla Chaikovska; Igor Pasteur; Ilya Likhtarov; Andre Bouville; Victor Shpak; Olena Bolshova; Galyna Zamotayeva; Katherine Grantz; Liping Sun; Kiyohiko Mabuchi; Paul Albert; Mykola Tronko
Journal:  Eur J Epidemiol       Date:  2017-08-30       Impact factor: 8.082

5.  A screening study of thyroid cancer and other thyroid diseases among individuals exposed in utero to iodine-131 from Chernobyl fallout.

Authors:  M Hatch; A Brenner; T Bogdanova; A Derevyanko; N Kuptsova; I Likhtarev; A Bouville; V Tereshchenko; L Kovgan; V Shpak; E Ostroumova; E Greenebaum; L Zablotska; E Ron; M Tronko
Journal:  J Clin Endocrinol Metab       Date:  2008-12-23       Impact factor: 5.958

Review 6.  Ionizing Radiation Exposure and Basal Cell Carcinoma Pathogenesis.

Authors:  Changzhao Li; Mohammad Athar
Journal:  Radiat Res       Date:  2016-03-01       Impact factor: 2.841

7.  Current use and future needs of biodosimetry in studies of long-term health risk following radiation exposure.

Authors:  Steven L Simon; André Bouville; Ruth Kleinerman
Journal:  Health Phys       Date:  2010-02       Impact factor: 1.316

8.  Clinical aspects of the health disturbances in Chernobyl Nuclear Power Plant accident clean-up workers (liquidators) from Latvia.

Authors:  M E Eglite; T J Zvagule; K D Rainsford; J D Reste; E V Curbakova; N N Kurjane
Journal:  Inflammopharmacology       Date:  2009-06-13       Impact factor: 4.473

9.  Doses for post-Chernobyl epidemiological studies: are they reliable?

Authors:  Vladimir Drozdovitch; Vadim Chumak; Ausrele Kesminiene; Evgenia Ostroumova; André Bouville
Journal:  J Radiol Prot       Date:  2016-06-29       Impact factor: 1.559

10.  Thyroid doses in Ukraine due to 131I intake after the Chornobyl accident. Report II: dose estimates for the Ukrainian population.

Authors:  Sergii Masiuk; Mykola Chepurny; Valentyna Buderatska; Olga Ivanova; Zulfira Boiko; Natalia Zhadan; Galyna Fedosenko; Andriy Bilonyk; Alexander Kukush; Tatiana Lev; Mykola Talerko; Vladimir Drozdovitch
Journal:  Radiat Environ Biophys       Date:  2021-08-05       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.